Queshi Zhiji No. 2 Private Securities Investment Fund, managed by Hangzhou Queshi Private Equity Fund Management Co., Ltd. signed share transfer agreement to acquire 5.6% stake in Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHSE:600613) from Guizhou Shenqi Holdings (Group) Co., Ltd. for CNY 190 million on March 21, 2024.
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.
Equities
600613
CNE000000453
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.19 CNY | +1.14% | -0.80% | -18.66% |
1st Jan change | Capi. | |
---|---|---|
-18.66% | 437M | |
+40.73% | 734B | |
+32.83% | 591B | |
-6.30% | 350B | |
+15.15% | 315B | |
+4.05% | 276B | |
+15.00% | 238B | |
+9.78% | 206B | |
-5.52% | 204B | |
+6.17% | 161B |
- Stock Market
- Equities
- 600613 Stock
- News Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.
- Queshi Zhiji No. 2 Private Securities Investment Fund, managed by Hangzhou Queshi Private Equity Fund Management Co., Ltd. signed share transfer agreement to acquire 5.6% stake in Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. from Guizhou Shenqi Holdings Co., Ltd. for CNY 190 million.